DKK 7.0
(1.74%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -10.72 Million DKK | -8.59% |
2022 | -9.87 Million DKK | 33.52% |
2021 | -14.85 Million DKK | 55.68% |
2020 | -33.52 Million DKK | 19.03% |
2019 | -41.4 Million DKK | 31.08% |
2018 | -60.08 Million DKK | -3998.43% |
2017 | -1.46 Million DKK | 81.26% |
2016 | -7.82 Million DKK | 46.06% |
2015 | -14.5 Million DKK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -6.92 Million DKK | 35.41% |
2024 Q2 | -3.43 Million DKK | 50.41% |
2023 Q2 | -3.25 Million DKK | 49.69% |
2023 Q4 | -10.72 Million DKK | -857.77% |
2023 Q1 | -6.46 Million DKK | 34.58% |
2023 Q3 | -1.12 Million DKK | 65.55% |
2023 FY | -10.72 Million DKK | -8.59% |
2022 Q1 | -10.87 Million DKK | 26.85% |
2022 FY | -9.87 Million DKK | 33.52% |
2022 Q4 | -9.87 Million DKK | 11.59% |
2022 Q3 | -11.17 Million DKK | -141.01% |
2022 Q2 | -4.63 Million DKK | 57.35% |
2021 Q3 | -17.47 Million DKK | 18.05% |
2021 Q1 | -23.56 Million DKK | 29.72% |
2021 FY | -14.85 Million DKK | 55.68% |
2021 Q4 | -14.85 Million DKK | 14.97% |
2021 Q2 | -21.32 Million DKK | 9.5% |
2020 Q2 | -39.43 Million DKK | -10.38% |
2020 FY | -33.52 Million DKK | 19.03% |
2020 Q3 | -38.02 Million DKK | 3.56% |
2020 Q4 | -33.52 Million DKK | 11.84% |
2020 Q1 | -35.72 Million DKK | 13.72% |
2019 Q2 | -50.16 Million DKK | 10.41% |
2019 FY | -41.4 Million DKK | 31.08% |
2019 Q4 | -41.4 Million DKK | 13.06% |
2019 Q3 | -47.62 Million DKK | 5.06% |
2019 Q1 | -55.99 Million DKK | 6.81% |
2018 Q1 | 629 Thousand DKK | 142.91% |
2018 FY | -60.08 Million DKK | -3998.43% |
2018 Q3 | -62.59 Million DKK | 10.99% |
2018 Q4 | -60.08 Million DKK | 4.01% |
2018 Q2 | -70.32 Million DKK | -11279.95% |
2017 Q1 | 7.82 Million DKK | 0.0% |
2017 Q4 | -1.46 Million DKK | 0.0% |
2017 FY | -1.46 Million DKK | 81.26% |
2016 FY | -7.82 Million DKK | 46.06% |
2015 FY | -14.5 Million DKK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Ambu A/S | 427 Million DKK | 102.512% |
ChemoMetec A/S | -291.99 Million DKK | 96.326% |
Demant A/S | 13.31 Billion DKK | 100.081% |
GN Store Nord A/S | 11.33 Billion DKK | 100.095% |
Scandinavian Medical Solutions A/S | 20.68 Million DKK | 151.858% |